Sabin Vaccine Institute [to 19 March 2016]
http://www.sabin.org/updates/ressreleases

.
03.17.16
Sabin Publishes on Challenges and Way Forward for Effective Dengue Vaccine Communication and Advocacy
International efforts to improve dengue communication and advocacy have increased over the last years, as dengue becomes one of the fastest spreading vector-borne diseases. However, few concerted efforts have been agreed upon at the international level to effectively communicate about dengue vaccines. The recent approvals in Mexico, the Philippines, Brazil and El Salvador of the first dengue vaccine, Dengvaxia®, coupled with the progress of seven other vaccine candidates, call for urgent focus on this topic. Dengue-endemic countries need scientific evidence to inform their decisions on vaccine introduction. Waiting to plan until vaccine licensure, as routinely occurs, may unnecessarily delay access to dengue vaccines in developing countries by years.

Where do we stand today in understanding dengue vaccines? What has been done to generate knowledge in this area and how has it been communicated? The Sabin Vaccine Institute seeks to answer these questions in a new publication titled “International Dengue Vaccine Communication and Advocacy: Challenges and Way Forward,” published today in a Dengue Special Edition of Expert Review of Vaccines. This special edition also includes important updates on dengue vaccine development…